Previous Page  7 / 24 Next Page
Information
Show Menu
Previous Page 7 / 24 Next Page
Page Background

Page 33

Notes:

conferenceseries

.com

Volume 8, Issue 3 (Suppl)

J Clin Exp Dermatol Res, an open access journal

ISSN: 2155-9554

Euro Dermatology 2017

June 07-08, 2017

June 07-08, 2017 Milan, Italy

16

th

European Dermatology Congress

New technique for the treatment of active acne after failure of Accutane, antibiotics and topical Rx’s, also

a non-prescription approach to treatment

Abnoeal Bakus, Dina Yaghmai, Mary Massa, Jeehan Qadir, Burcu Hurbas

and

Jerome Garden

Physicians Laser and Dermatology Institute

LLC Chicago

IL United States of America

American Academy of Cosmetic Surgery Dubai, UAE

Background:

Adult acne can be challenging to treat. Laser therapy has made advances in treating inflammatory acne. Some of the

successful laser devices used may also reduce hair growth which would be undesirable in the beard region of male patients.

Aim:

To evaluate a device based, non-topical acne medication or oral antibiotic treatment of active acne over the beard area.

Study:

A total of 10 male patients with moderate to severe acne over the beard region were treated. Patients stopped using all the

topical and oral anti-acne medications. Skin types included I-IV. A QSYAG laser at 1064 nm, 6 mm and 0.9-1.3 j/cm2 was used for

therapy. Patients were treated every 2 to 4 weeks depending on their level of acne severity.

Results:

Patients responded with a significant reduction in acne lesions. At least 6 sessions were administered. There were no adverse

effects except for immediate transient erythema and edema. Long term results were maintained after therapy. Beard hair growth

remained at pre-laser therapy levels.

Conclusion:

Laser therapy is an effective and safe method for treating the male beard area in patients with inflammatory acne.

Appropriate laser selection and parameters are necessary to achieve.

Biography

Abnoeal D Bakus received his Ph.D. in Bio-Laser Research through the Department of Physics at the Illinois Institute of Technology, after receiving a Masters

in Radiobiology at DePaul University. He did post-graduate work in laser-tissue interaction at Northwestern University Department of Dermatology and then a

researcher in the Department of Biomedical Engineering. For more than 20 years, has been involved in laser skin studies.

Bakus has been Co-Director of Clinical Research at Physicians Laser and Dermatology Institute, participating in and overseeing all ongoing projects. He is

an author of multiple medical articles and chapters, and has been involved in developing patents and teaching laser therapy at various medical seminars around

the world.

bakus_laser@hotmail.com

Abnoeal Bakus et al., J Clin Exp Dermatol Res 2017, 8:3 (Suppl)

DOI:10.4172/2155-9554-C1-056